Mesa Laboratories, Inc.

NASDAQ:MLAB

Hardware, Equipment & Parts

Technology
$137.81 -0.16%

-$0.15 today

Market cap
$774.56M
Beta
0.93
P/E (TTM)
78.3
EPS (TTM)
$1.21
Dividend yield
0.68%
52W Low $55.45High $113.99

Volume 0.07M

Average 0.16M

MLAB Short-term Investments

Marketable securities and deposits the company expects to convert to cash within a year.

Mesa Laboratories, Inc.NASDAQ: MLAB

Short-term Investments · Q4 FY2026 · quarter ended Mar 2026

Short-term investments remains negative

Q4 FY2026 short-term investments was $0, compared with $0 a year earlier.

Context

  • Short-term investments amounted to 0.0% of total assets at the end of Q4 FY2026, unchanged from a year earlier.
  • Short-term investments increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearMar 2026
$0— YoY
Year agoMar 2025
$0— since
Short-term Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Short-term Investments history

USD · from the balance sheet

Latest · FY2026
0 USD
Year-over-year change
—

Short-term Investments vs competitors

How MLAB compares with its peers on the latest reported figures

  • MLAB's Mar 2026 short-term investments of $0 is the 8th highest of the 11 companies compared; the peer median is $37.25M.
  • Short-term investments amounts to 0.0% of total assets for MLAB, versus a peer median of 0.5%.
MLAB Competitors Peer median
Short-term Investments for MLAB and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BIOBio-Rad Laboratories, Inc.Jun 2026$1.1B +9.7%-9.3%10.7%
TMOThermo Fisher Scientific Inc.Sep 2026$600M -61.6%—0.5%
PACBPacific Biosciences of California, Inc.Mar 2026$219.69M -22.8%-21.6%28.1%
LABStandard BioTools Inc.Mar 2026$189.4M +76.7%-6.4%29.6%
TXG10x Genomics, Inc.Sep 2026$49.49M -0.2%-38.3%4.7%
QGENQiagen N.V.Jun 2026$25M -88.6%-27.7%0.4%
TECHBio-Techne CorporationSep 2026$1.09M ——0.0%
MLABMesa Laboratories, Inc.Mar 2026$0 ——0.0%
AAgilent Technologies, Inc.Jul 2026$0 ——0.0%
RVTYRevvity, Inc.Jul 2026$0 ——0.0%
MRVIMaravai LifeSciences Holdings, Inc.Jun 2026$0 ——0.0%
Peer median (excluding MLAB) $37.25M-11.5%-21.6%0.5%

Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Cash & Equivalents49.35M32.91M28.21M27.32M26.93M
Short-term Investments00000
Net Receivables41.22M42.55M39.06M41.97M44.1M
Inventory24.61M34.64M32.68M25.37M26.37M
Other Current Assets9.14M4.05M3.34M2.87M3.62M
Total Current Assets124.32M118.98M109.35M102.69M106.27M
Property, Plant & Equipment (Net)28.62M28.15M41.44M32.33M48.11M
Goodwill291.17M286.44M180.1M181.76M186.86M
Intangible Assets250.12M216.82M113.75M96.88M83.35M
Long-term Investments00000
Tax Assets1.32M1.08M1.29M1.37M1.5M
Other Non-current Assets11.83M10.37M867K18.32M1.66M
Total Non-current Assets583.05M542.86M337.44M330.66M321.48M
Total Assets707.37M661.83M446.8M433.35M427.75M
Account Payables7.9M6.13M6.04M5.75M4.93M
Short-term Debt000101.05M5.63M
Tax Payables7.96M8.92M1.62M10.63M0
Deferred Revenue14.58M15.69M15.48M14.71M14.72M
Other Current Liabilities0015.49M011.5M
Total Current Liabilities48.06M43.36M44.31M163.96M61.9M
Long-term Debt218.37M183.27M221.7M76.9M145.86M
Deferred Tax Liabilities39.22M34.03M19.78M20.18M20.09M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.92M7.69M9M12.47M0
Total Non-current Liabilities265.51M224.99M257.09M109.56M179.6M
Total Liabilities313.57M268.35M301.4M273.52M241.5M
Common Stock313.46M332.08M343.64M358.54M375.35M
Retained Earnings76.68M74.2M(183.49M)(188.94M)(185.75M)
Accumulated OCI3.67M(12.8M)(14.76M)(9.78M)(3.36M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity393.8M393.48M145.39M159.83M186.25M
Total Debt221.13M186.14M231.3M181.47M168.83M
Net Debt171.79M153.23M203.08M154.15M141.9M

Mesa Laboratories, Inc.

NASDAQ:MLAB

Intrinsic Alpha fair value

Locked

Current Price

$137.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.